Reata Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise over 13% on the day. The news led to far more shares changing hands than in a normal session, resulting in solid volume. This reverses the recent trend for the company as the stock is now up 82.6% in the past one-month time frame.

The company has seen one positive estimate revision in the last 30 days, while its Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Reata Pharmaceuticals has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Another favorably placed stock in the same industry is ANI Pharmaceuticals, Inc. (ANIP Quick QuoteANIP - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is RETA going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>